Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Topline phase III data from active-comparator ARCH study of Evenity

May 22, 2017

Erx Pharmaceuticals synthesizes novel celastrol derivatives

May 22, 2017

CHMP recommends approval of Insulin lispro Sanofi

May 22, 2017

EMA committee hands down positive opinion on Veltassa for treatment of hyperkalemia

May 19, 2017

ObsEva completes phase I drug-drug interaction study with OBE-022

May 19, 2017

rAAV9-CBA-hNAGLUop optimized gene delivery for treating MPS IIIB

May 18, 2017

Promising clinical results seen with AAV2-AADC for AADC deficiency

May 18, 2017

LV.CD11b.IDS for the treatment of neurocognitive impairments in an MPS II mouse model

May 18, 2017

Catalent to support development of Therachon's TA-46 for achondroplasia

May 17, 2017

Mitsubishi Tanabe Pharma presents CYP11B2 inhibitors

May 17, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 9, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Lilly shifts from obesity to narcolepsy with $7.8B Centessa buy
BioWorld
Eli Lilly and Co. plans to buy Centessa Pharmaceuticals plc for $6.3 billion in up-front cash and another potential $1.5 billion through contingent value rights,...